STEMPOINT CAPITAL LP
Q3 2026 13F-HR Holdings
Net value change ($000)
-20,977
(-3.6%)
New positions
39
Sold out positions
31
Turnover %
61.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| SRRK | 20,137 | 153.1% |
| ADPT | 13,397 | NEW |
| SNSE | 12,042 | NEW |
| IMTX | 11,486 | NEW |
| GRAL | 11,479 | NEW |
| ROIV | 11,129 | 90.3% |
| ACRS | 10,787 | NEW |
| DAMORA THERAPEUTICS INC | 10,769 | NEW |
| FIRST TRACKS BIOTHERAPEUTICS | 10,504 | 83.8% |
| ONC | 9,167 | NEW |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
1,119
(0.2% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|